Aram Huvis Pioneers AI-Driven Personalized Cosmetics with Global Expansion Strategy

Aram Huvis, a South Korean technology company specializing in AI-powered scalp and skin diagnostics, is poised to transform the global cosmetics industry through its innovative personalized care solutions. With a robust technology platform developed over 22 years, the company has attracted international attention from major beauty brands and is aggressively expanding its global market presence.

The company's flagship AI Scalp Grader (AISG) technology enables real-time personalized product formulation, offering customized shampoos and serums based on individual diagnostic data. Clinically validated by dermatologists from Seoul National University Bundang Hospital, Aram Huvis' solutions have demonstrated remarkable efficacy, with a clinical trial showing a 51% reduction in risk factors and a 93% participant satisfaction rate.

Aram Huvis is transitioning from a business-to-business model to direct consumer sales, targeting global markets through strategic partnerships with leading cosmetics brands like LVMH, L'Oréal, and Estée Lauder. The company currently exports products to 70 countries and operates through 30 international distributors, with recent negotiations targeting expansion in Israel, India, Portugal, Panama, Switzerland, and Qatar.

Investing significantly in research and development, Aram Huvis allocates 18.92% of its revenue to innovation—substantially higher than South Korea's corporate average of 2.89%. This commitment enables the development of sophisticated diagnostic solutions and preservative-free, natural ingredient cosmetics catering to consumers with sensitive skin.

In 2025, the company plans to launch new brands including Medi Custom, targeting specialized hand creams for healthcare professionals, and Lilai, a personalized scalp care line. These strategic moves demonstrate Aram Huvis' commitment to diversifying its product portfolio and accelerating business growth in the competitive beauty technology sector.